Oakwood's Products
Oakwood Laboratories maintains a strong proactive effort focusing on the in and out licensing of products and technology. We actively search for products and technology that align with the therapeutic markets of urology, oncology and endocrinology. We are seeking development and marketing partners for the following products/projects:
| Products | Diseases |
Status |
License Availability |
| Leuprolide 14-day-kit | prostate cancer | Approved | Outside N. America |
| Leuprolide 3.75 mg (1 month depot) | prostate cancer | pre-clinical | Outside N. America |
| Leuprolide 7.5 mg (1 month depot) | prostate cancer | NDA Submission | Outside N. America |
| Leuprolide 22.5 mg (3 month depot) | prostate cancer | NDA Submission | Outside N. America |
| Leuprolide 30 mg (4 month depot) | prostate cancer | pre-clinical | Outside N. America |
| Leuprolide 45 mg (6 month depot) | prostate cancer | pre-clinical | Outside N. America |
| Octreotide (1 month depot) | acromegaly | pre-clinical | World |
| Risperidone | schizophrenia | pre-clinical | World |
| Dermal fill | cosmetic | pre-clinical | World |
